Published in J Clin Oncol on June 03, 2013
Continuous Combined Estrogen Plus Progestin and Endometrial Cancer: The Women's Health Initiative Randomized Trial. J Natl Cancer Inst (2015) 1.41
Adiposity and cancer risk: new mechanistic insights from epidemiology. Nat Rev Cancer (2015) 1.32
Antiproliferative and metabolic effects of metformin in a preoperative window clinical trial for endometrial cancer. Cancer Med (2014) 1.10
Direct effects of metformin in the endometrium: a hypothetical mechanism for the treatment of women with PCOS and endometrial carcinoma. J Exp Clin Cancer Res (2014) 0.96
Ovarian Cancer Risk Factors by Histologic Subtype: An Analysis From the Ovarian Cancer Cohort Consortium. J Clin Oncol (2016) 0.96
Is diabetes mellitus associated with increased incidence and disease-specific mortality in endometrial cancer? A systematic review and meta-analysis of cohort studies. Gynecol Oncol (2014) 0.95
The emerging genomic landscape of endometrial cancer. Clin Chem (2013) 0.94
Metabolic syndrome and risk of endometrial cancer in the united states: a study in the SEER-medicare linked database. Cancer Epidemiol Biomarkers Prev (2015) 0.92
Risk factors for endometrial cancer in black and white women: a pooled analysis from the Epidemiology of Endometrial Cancer Consortium (E2C2). Cancer Causes Control (2014) 0.90
Parity and endometrial cancer risk: a meta-analysis of epidemiological studies. Sci Rep (2015) 0.90
Risk-scoring models for individualized prediction of overall survival in low-grade and high-grade endometrial cancer. Gynecol Oncol (2014) 0.89
DNA mismatch repair-related protein loss as a prognostic factor in endometrial cancers. J Gynecol Oncol (2014) 0.87
Secondary solid cancer screening following hematopoietic cell transplantation. Bone Marrow Transplant (2015) 0.86
Fertility drugs and endometrial cancer risk: results from an extended follow-up of a large infertility cohort. Hum Reprod (2013) 0.86
Genetic Risk Score Mendelian Randomization Shows that Obesity Measured as Body Mass Index, but not Waist:Hip Ratio, Is Causal for Endometrial Cancer. Cancer Epidemiol Biomarkers Prev (2016) 0.83
Tissue Factor-Factor VII Complex As a Key Regulator of Ovarian Cancer Phenotypes. Biomark Cancer (2015) 0.82
Intrauterine devices and endometrial cancer risk: a pooled analysis of the Epidemiology of Endometrial Cancer Consortium. Int J Cancer (2014) 0.82
Multivariate Analysis of Prognostic Biomarkers in Surgically Treated Endometrial Cancer. PLoS One (2015) 0.81
Parity Correlates with the Timing of Developing Endometrial Cancer, But Not Subtype of Endometrial Cancer. J Cancer (2015) 0.81
Risk factors for endometrial cancer among women with a BRCA1 or BRCA2 mutation: a case control study. Fam Cancer (2015) 0.81
Body Mass Index Is Positively Associated with Endometrial Cancer in Chinese Women, Especially Prior to Menopause. J Cancer (2016) 0.81
Coffee consumption and risk of endometrial cancer: a dose-response meta-analysis of prospective cohort studies. Sci Rep (2015) 0.80
Sugar-sweetened beverage intake and the risk of type I and type II endometrial cancer among postmenopausal women. Cancer Epidemiol Biomarkers Prev (2013) 0.80
PCOS and obesity: insulin resistance might be a common etiology for the development of type I endometrial carcinoma. Am J Cancer Res (2014) 0.80
A systematic review and meta-analysis of physical activity and endometrial cancer risk. Eur J Epidemiol (2015) 0.79
Progesterone receptor isoforms A and B: new insights into the mechanism of progesterone resistance for the treatment of endometrial carcinoma. Ecancermedicalscience (2013) 0.79
Long-chain ω-3 fatty acid intake and endometrial cancer risk in the Women's Health Initiative. Am J Clin Nutr (2015) 0.79
Dietary intake of acrylamide and endometrial cancer risk in the European Prospective Investigation into Cancer and Nutrition cohort. Br J Cancer (2014) 0.79
Cigarette smoking and endometrial carcinoma risk: the role of effect modification and tumor heterogeneity. Cancer Causes Control (2014) 0.79
The levels of the sex hormones are not different between type 1 and type 2 endometrial cancer. Sci Rep (2016) 0.78
Radiation-Associated Toxicities in Obese Women with Endometrial Cancer: More Than Just BMI? ScientificWorldJournal (2015) 0.78
Prognostic importance of DNA ploidy in non-endometrioid, high-risk endometrial carcinomas. Oncol Lett (2016) 0.78
Childhood body mass index and height and risk of histologic subtypes of endometrial cancer. Int J Obes (Lond) (2016) 0.78
Serum Estrogens and Estrogen Metabolites and Endometrial Cancer Risk among Postmenopausal Women. Cancer Epidemiol Biomarkers Prev (2016) 0.78
CYP19A1 fine-mapping and Mendelian randomization: estradiol is causal for endometrial cancer. Endocr Relat Cancer (2015) 0.78
Establishment of human patient-derived endometrial cancer xenografts in NOD scid gamma mice for the study of invasion and metastasis. PLoS One (2014) 0.77
Endometrial Cancer Insulin-Like Growth Factor 1 Receptor (IGF1R) Expression Increases with Body Mass Index and Is Associated with Pathologic Extent and Prognosis. Cancer Epidemiol Biomarkers Prev (2015) 0.77
Long-term impact of preeclampsia on maternal endometrial cancer risk. Br J Cancer (2016) 0.77
The Obesity-Breast Cancer Conundrum: An Analysis of the Issues. Int J Mol Sci (2016) 0.76
Lifestyle changes and the risk of developing endometrial and ovarian cancers: opportunities for prevention and management. Int J Womens Health (2016) 0.76
Mutational analysis of the tyrosine kinome in serous and clear cell endometrial cancer uncovers rare somatic mutations in TNK2 and DDR1. BMC Cancer (2014) 0.76
Buformin exhibits anti-proliferative and anti-invasive effects in endometrial cancer cells. Am J Transl Res (2016) 0.76
Endometrial cancer in morbidly obese women: do racial disparities affect surgical or survival outcomes? Gynecol Oncol (2014) 0.76
Joint Effect of Genotypic and Phenotypic Features of Reproductive Factors on Endometrial Cancer Risk. Sci Rep (2015) 0.76
Adult Comorbidity Evaluation 27 score as a predictor of survival in endometrial cancer patients. Am J Obstet Gynecol (2016) 0.76
Case Report of Menopausal Woman Diagnosed with Endometrial Cancer after Colon Cancer with Germline Mutation in MSH6 in Korea. J Menopausal Med (2017) 0.75
Dietary fat intake and endometrial cancer risk: A dose response meta-analysis. Medicine (Baltimore) (2016) 0.75
History of uterine leiomyoma and risk of endometrial cancer in black women. Cancer Causes Control (2016) 0.75
Dedifferentiated endometrioid carcinoma of the uterus : report of four cases and review of literature. World J Surg Oncol (2017) 0.75
Androgen receptors are acquired by healthy postmenopausal endometrial epithelium and their subsequent loss in endometrial cancer is associated with poor survival. Br J Cancer (2016) 0.75
Comparison of Risk Factors and survival of Type 1 and Type II Endometrial Cancers. Pak J Med Sci (2016) 0.75
Features of omental adipose tissue in endometrial cancer patients with 'standard' or 'metabolically healthy' obesity: associations with tumor process characteristics. Springerplus (2016) 0.75
Genome-wide analysis of gynecologic cancer: The Cancer Genome Atlas in ovarian and endometrial cancer. Oncol Lett (2017) 0.75
Body size over the life-course and the risk of endometrial cancer: the California Teachers Study. Cancer Causes Control (2016) 0.75
Endometriosis and risk of ovarian and endometrial cancers in a large prospective cohort of U.S. nurses. Cancer Causes Control (2017) 0.75
Stromal p16 expression is significantly increased in endometrial carcinoma. Oncotarget (2016) 0.75
Symposium on advances in endometrial cancer epidemiology and biology. Gynecol Oncol (2015) 0.75
An update of the classical Bokhman's dualistic model of endometrial cancer. Prz Menopauzalny (2016) 0.75
H19 promotes endometrial cancer progression by modulating epithelial-mesenchymal transition. Oncol Lett (2016) 0.75
Promising clinical practices of metformin in women with PCOS and early-stage endometrial cancer. BBA Clin (2014) 0.75
Features of endometrial cancer in patients with 'metabolically healthy' versus 'standard' obesity: the decreasing frequency of metabolically healthy obesity. Future Sci OA (2015) 0.75
Lean Body Weight and Metformin Are Insufficient to Prevent Endometrial Hyperplasia in Mice Harboring Inactivating Mutations in PTEN. Oncology (2016) 0.75
Dietary patterns and endometrial cancer risk in the California Teachers Study cohort. Cancer Causes Control (2015) 0.75
Is the positivity of estrogen receptor or progesterone receptor different between type 1 and type 2 endometrial cancer? Oncotarget (2016) 0.75
Does hysteroscopy worsen prognosis in women with type II endometrial carcinoma? PLoS One (2017) 0.75
Infertility and incident endometrial cancer risk: a pooled analysis from the epidemiology of endometrial cancer consortium (E2C2). Br J Cancer (2015) 0.75
Conditional abrogation of Transforming Growth Factor Beta Receptor 1 in PTEN-inactivated endometrium promotes endometrial cancer progression in mice. J Pathol (2017) 0.75
Endometrial Cancer Trends by Race and Histology in the USA: Projecting the Number of New Cases from 2015 to 2040. J Racial Ethn Health Disparities (2016) 0.75
GPER modulators: Opportunity Nox on the heels of a class Akt. J Steroid Biochem Mol Biol (2017) 0.75
The Importance of Steroid Uptake and Intracrine Action in Endometrial and Ovarian Cancers. Front Pharmacol (2017) 0.75
Loss of Mismatch Repair Protein Expression in Unselected Endometrial Adenocarcinoma Precursor Lesions. Int J Gynecol Cancer (2016) 0.75
Risk of cardiovascular disease among women with endometrial cancer compared to cancer-free women in the Women's Health Initiative. Cancer Epidemiol (2017) 0.75
ASCT2 regulates glutamine uptake and cell growth in endometrial carcinoma. Oncogenesis (2017) 0.75
The Association of CYP19A1 Variation with Circulating Estradiol and Aromatase Inhibitor Outcome: Can CYP19A1 Variants Be Used to Predict Treatment Efficacy? Front Pharmacol (2017) 0.75
Two pathogenetic types of endometrial carcinoma. Gynecol Oncol (1983) 6.26
Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review. Cancer Epidemiol Biomarkers Prev (2002) 5.34
The dose-effect relationship between 'unopposed' oestrogens and endometrial mitotic rate: its central role in explaining and predicting endometrial cancer risk. Br J Cancer (1988) 3.07
Obesity and cancer. Oncogene (2004) 3.01
Molecular and pathologic aspects of endometrial carcinogenesis. J Clin Oncol (2006) 2.59
Should grade 3 endometrioid endometrial carcinoma be considered a type 2 cancer-a clinical and pathological evaluation. Gynecol Oncol (2011) 2.57
Diabetes mellitus and risk of endometrial cancer: a meta-analysis. Diabetologia (2007) 2.54
Theories of endometrial carcinogenesis: a multidisciplinary approach. Mod Pathol (2000) 2.16
A direct effect of hyperinsulinemia on serum sex hormone-binding globulin levels in obese women with the polycystic ovary syndrome. J Clin Endocrinol Metab (1991) 1.96
Plasma adiponectin levels and endometrial cancer risk in pre- and postmenopausal women. J Clin Endocrinol Metab (2006) 1.71
Factors associated with Type I and Type II endometrial cancer. Cancer Causes Control (2010) 1.52
Body size in relation to cancer of the uterine corpus in 1 million Norwegian women. Int J Cancer (2007) 1.43
Cigarette smoking and the risk of endometrial cancer: a meta-analysis. Am J Med (2008) 1.38
Obesity, inflammatory markers, and endometrial cancer risk: a prospective case-control study. Endocr Relat Cancer (2010) 1.35
Prediagnostic levels of C-peptide, IGF-I, IGFBP -1, -2 and -3 and risk of endometrial cancer. Int J Cancer (2004) 1.33
Endometrial carcinoma: pathology and genetics. Pathology (2007) 1.32
Body mass and endometrial cancer risk by hormone replacement therapy and cancer subtype. Cancer Epidemiol Biomarkers Prev (2008) 1.30
Smoking and the risk of endometrial cancer: results from the Nurses' Health Study. Int J Cancer (2005) 1.22
Hormonal interactions in endometrial cancer. Endocr Relat Cancer (2000) 1.20
Risk factors and hormone levels in patients with serous and endometrioid uterine carcinomas. Mod Pathol (1997) 1.14
Endometrial cancer risk factors by 2 main histologic subtypes: the NIH-AARP Diet and Health Study. Am J Epidemiol (2012) 1.10
Uterine papillary serous carcinoma. Clin Obstet Gynecol (2011) 1.09
Maximizing resources to study an uncommon cancer: E2C2--Epidemiology of Endometrial Cancer Consortium. Cancer Causes Control (2009) 1.03
Molecular profile of grade 3 endometrioid endometrial carcinoma: is it a type I or type II endometrial carcinoma? Am J Surg Pathol (2012) 1.00
Risk of endometrial cancer in relationship to cigarette smoking: results from the EPIC study. Int J Cancer (2007) 0.99
Endometrial carcinomas with ambiguous features. Semin Diagn Pathol (2010) 0.97
Cigarette smoke increases progesterone receptor and homeobox A10 expression in human endometrium and endometrial cells: a potential role in the decreased prevalence of endometrial pathology in smokers. Biol Reprod (2011) 0.94
Dietary and supplemental intake of one-carbon nutrients and the risk of type I and type II endometrial cancer: a prospective cohort study. Ann Oncol (2011) 0.92
Active and passive cigarette smoking and the risk of endometrial cancer in Poland. Eur J Cancer (2009) 0.87
EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib. Proc Natl Acad Sci U S A (2004) 33.85
Mortality results from a randomized prostate-cancer screening trial. N Engl J Med (2009) 30.05
Genome-wide association study identifies novel breast cancer susceptibility loci. Nature (2007) 29.23
Role of computerized physician order entry systems in facilitating medication errors. JAMA (2005) 26.32
A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. Nat Genet (2007) 22.96
Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. J Natl Cancer Inst (2004) 19.00
Assessing the impact of population stratification on genetic association studies. Nat Genet (2004) 16.28
A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25. Nature (2008) 16.10
Common variants near MC4R are associated with fat mass, weight and risk of obesity. Nat Genet (2008) 15.94
Multiple regions within 8q24 independently affect risk for prostate cancer. Nat Genet (2007) 14.37
Body-mass index and mortality among 1.46 million white adults. N Engl J Med (2010) 13.34
Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature (2011) 13.25
Genome-wide association study identifies eight loci associated with blood pressure. Nat Genet (2009) 12.44
Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol (2011) 12.10
Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: mortality results after 13 years of follow-up. J Natl Cancer Inst (2012) 11.91
Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy. N Engl J Med (2012) 11.48
Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer. Proc Natl Acad Sci U S A (2005) 10.89
Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor-positive breast cancer. Nat Genet (2007) 10.81
Genome-wide association study reveals genetic risk underlying Parkinson's disease. Nat Genet (2009) 10.34
Admixture mapping identifies 8q24 as a prostate cancer risk locus in African-American men. Proc Natl Acad Sci U S A (2006) 10.32
Association between mortality and indicators of traffic-related air pollution in the Netherlands: a cohort study. Lancet (2002) 9.69
Effect of screening on ovarian cancer mortality: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial. JAMA (2011) 9.13
Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality. JAMA (2010) 8.93
Calcium plus vitamin D supplementation and the risk of colorectal cancer. N Engl J Med (2006) 8.73
A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1). Nat Genet (2009) 8.39
Large-scale genotyping identifies 41 new loci associated with breast cancer risk. Nat Genet (2013) 8.24
The Nurses' Health Study: lifestyle and health among women. Nat Rev Cancer (2005) 8.19
Ethnic and racial differences in the smoking-related risk of lung cancer. N Engl J Med (2006) 7.82
Common variants on chromosome 5p12 confer susceptibility to estrogen receptor-positive breast cancer. Nat Genet (2008) 7.65
Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis. JAMA (2003) 7.42
Factors influencing the composition of the intestinal microbiota in early infancy. Pediatrics (2006) 7.40
A common coding variant in CASP8 is associated with breast cancer risk. Nat Genet (2007) 7.35
Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2. Nat Genet (2009) 7.30
Dietary and supplemental calcium intake and cardiovascular disease mortality: the National Institutes of Health-AARP diet and health study. JAMA Intern Med (2013) 7.30
Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing. Proc Natl Acad Sci U S A (2012) 7.14
Estrogen plus progestin and breast cancer incidence and mortality in postmenopausal women. JAMA (2010) 7.12
A common genetic risk factor for colorectal and prostate cancer. Nat Genet (2007) 7.11
The 8q24 cancer risk variant rs6983267 shows long-range interaction with MYC in colorectal cancer. Nat Genet (2009) 6.99
Sequence variants at the TERT-CLPTM1L locus associate with many cancer types. Nat Genet (2009) 6.91
Association between body-mass index and risk of death in more than 1 million Asians. N Engl J Med (2011) 6.89
TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal. Proc Natl Acad Sci U S A (2013) 6.88
Sequence variant on 8q24 confers susceptibility to urinary bladder cancer. Nat Genet (2008) 6.69
Dietary supplements and mortality rate in older women: the Iowa Women's Health Study. Arch Intern Med (2011) 6.69
Diagnostic markers for early detection of ovarian cancer. Clin Cancer Res (2008) 6.47
Screening by chest radiograph and lung cancer mortality: the Prostate, Lung, Colorectal, and Ovarian (PLCO) randomized trial. JAMA (2011) 6.45
Epidemiologic evaluation of measurement data in the presence of detection limits. Environ Health Perspect (2004) 6.43
Dietary fat reduction and breast cancer outcome: interim efficacy results from the Women's Intervention Nutrition Study. J Natl Cancer Inst (2006) 6.41
Insulin-like growth factors and neoplasia. Nat Rev Cancer (2004) 6.29
Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study. J Natl Cancer Inst (2003) 6.28
Genetic variation and cancer: improving the environment for publication of association studies. Cancer Epidemiol Biomarkers Prev (2004) 6.24
Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics. PLoS Genet (2008) 6.22
American College of Sports Medicine roundtable on exercise guidelines for cancer survivors. Med Sci Sports Exerc (2010) 6.18
Air pollution and lung cancer incidence in 17 European cohorts: prospective analyses from the European Study of Cohorts for Air Pollution Effects (ESCAPE). Lancet Oncol (2013) 6.12
Common sequence variants on 2p15 and Xp11.22 confer susceptibility to prostate cancer. Nat Genet (2008) 6.10
Breast cancer incidence, 1980-2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status. J Natl Cancer Inst (2007) 6.08
Identification of seven new prostate cancer susceptibility loci through a genome-wide association study. Nat Genet (2009) 6.04
Lung cancer susceptibility locus at 5p15.33. Nat Genet (2008) 5.99